$IGC

I.G.C. Inc, (NYSE: IGC) is a biopharmaceutical company that engages in discovering, developing, and patenting the cannabinoid processes and compounds that are to be used in medicines and combination therapies. IGC believes by leveraging its current synergies with potential acquisitions from their investment bank should be able to should compound and rapidly grow their various divisions. IGC see’s the tremendous growth of a $8.9B industry and they have laid out the business model to execution this management team and advisors aims to build the industry’s premier conglomerate.